Dolby Laboratories (NYSE:DLB - Get Free Report)'s stock had its "hold (c)" rating reiterated by stock analysts at Weiss Ratings in a note issued to investors on Wednesday,Weiss Ratings reports.
Other equities analysts have also issued research reports about the stock. Tigress Financial boosted their target price on shares of Dolby Laboratories from $112.00 to $114.00 and gave the stock a "buy" rating in a research report on Friday, August 15th. Barrington Research reaffirmed an "outperform" rating and issued a $100.00 price target on shares of Dolby Laboratories in a report on Friday, September 12th. Baird R W raised Dolby Laboratories to a "hold" rating in a report on Friday, September 5th. Wall Street Zen raised Dolby Laboratories from a "hold" rating to a "buy" rating in a research note on Saturday, August 30th. Finally, Rosenblatt Securities reissued a "buy" rating and set a $95.00 price objective on shares of Dolby Laboratories in a research report on Friday, August 1st. Three investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $95.75.
Read Our Latest Research Report on DLB
Dolby Laboratories Price Performance
DLB traded up $1.12 during midday trading on Wednesday, hitting $71.05. 609,696 shares of the company's stock traded hands, compared to its average volume of 542,675. The company has a market cap of $6.81 billion, a PE ratio of 26.03 and a beta of 0.92. The stock's fifty day simple moving average is $72.36 and its 200-day simple moving average is $74.30. Dolby Laboratories has a one year low of $68.24 and a one year high of $89.66.
Dolby Laboratories (NYSE:DLB - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The electronics maker reported $0.78 EPS for the quarter, beating analysts' consensus estimates of $0.72 by $0.06. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The company had revenue of $315.55 million for the quarter, compared to analyst estimates of $305.23 million. During the same quarter last year, the firm posted $0.71 earnings per share. The company's quarterly revenue was up 9.2% compared to the same quarter last year. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. On average, research analysts expect that Dolby Laboratories will post 2.94 EPS for the current year.
Insider Activity
In other news, CEO Kevin J. Yeaman sold 25,000 shares of the business's stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $71.66, for a total value of $1,791,500.00. Following the completion of the transaction, the chief executive officer directly owned 114,725 shares in the company, valued at approximately $8,221,193.50. The trade was a 17.89% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Shriram Revankar sold 7,000 shares of the business's stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $74.92, for a total transaction of $524,440.00. Following the completion of the transaction, the senior vice president owned 70,435 shares of the company's stock, valued at $5,276,990.20. The trade was a 9.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 99,366 shares of company stock valued at $7,293,963 in the last quarter. Corporate insiders own 38.39% of the company's stock.
Hedge Funds Weigh In On Dolby Laboratories
A number of institutional investors have recently added to or reduced their stakes in the stock. Securian Asset Management Inc. increased its position in Dolby Laboratories by 3.0% during the 1st quarter. Securian Asset Management Inc. now owns 4,648 shares of the electronics maker's stock worth $373,000 after purchasing an additional 137 shares in the last quarter. Boothbay Fund Management LLC increased its position in Dolby Laboratories by 4.1% during the 2nd quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker's stock worth $299,000 after purchasing an additional 157 shares in the last quarter. MAI Capital Management increased its position in Dolby Laboratories by 87.1% during the 1st quarter. MAI Capital Management now owns 348 shares of the electronics maker's stock worth $28,000 after purchasing an additional 162 shares in the last quarter. Equitable Trust Co. increased its position in Dolby Laboratories by 3.3% during the 2nd quarter. Equitable Trust Co. now owns 5,567 shares of the electronics maker's stock worth $413,000 after purchasing an additional 177 shares in the last quarter. Finally, Net Worth Advisory Group increased its position in Dolby Laboratories by 5.2% in the 1st quarter. Net Worth Advisory Group now owns 3,591 shares of the electronics maker's stock valued at $288,000 after acquiring an additional 178 shares during the period. 58.56% of the stock is currently owned by institutional investors and hedge funds.
Dolby Laboratories Company Profile
(
Get Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.